Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
AusPAR: Doravirine and doravirine/ lamivudine/ tenofovir disoproxil fumarate
Australian Public Assessment Report
Device/Product Name
Pifeltro and Delstrigo
Active ingredients
Doravirine and doravirine/ lamivudine/ tenofovir disoproxil fumarate
AusPAR Date
Published
Submission Number
PM-2017-04580-1-2 and PM-2017-04581-1-2
Submission Type
New chemical entity and New fixed dose combination
Decision
Approved